Dendrimer-based excipients for the attenuation of protein aggregation

US9410142B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9410142-B2
Application numberUS-201113884420-A
CountryUS
Kind codeB2
Filing dateNov 11, 2011
Priority dateNov 11, 2010
Publication dateAug 9, 2016
Grant dateAug 9, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

One aspect of the invention is a salt comprising guanidinium groups, as shown in formula I. Another aspect of the invention is a salt comprising guanidinium groups, as shown in formula II. Another aspect of the invention is a salt comprising guanidinium groups, as shown in formula III. Another aspect of the invention is a salt comprising guanidinium groups, as shown in formula IV. Yet another aspect of the invention is a salt comprising guanidinium groups, as shown in formula I, II, III, and IV further comprising independently for each occurrence citrate, phosphate, or sulfate anion. Also disclosed are compositions comprising a protein and a salt comprising guanidinium groups, as shown in formula I, II, III, and IV. Also provided are methods of increasing shelf life of an aqueous solution of a protein and decreasing the amount of protein aggregation in an aqueous solution of a protein.

First claim

Opening claim text (preview).

We claim: 1. A salt, comprising a plurality of anions; and a cation represented by formula I: wherein, independently for each occurrence, each anion is Z is —CH 2 CH 2 —, —CH 2 CH 2 CH 2 —, —CH 2 CH 2 CH 2 CH 2 —, or —CH 2 CH 2 CH 2 CH 2 CH 2 —; Y is —CH 2 —, —CH 2 CH 2 —, —CH 2 CH 2 CH 2 —, —CH 2 CH 2 CH 2 CH 2 —, or —CH 2 CH 2 CH 2 CH 2 CH 2 —; X 1 is X 2 is and X 3 is 2. A salt, comprising a plurality of anions; and a cation represented by formula II: wherein, independently for each occurrence, each anion is Z is —CH 2 CH 2 —, —CH 2 CH 2 CH 2 —, —CH 2 CH 2 CH 2 CH 2 —, or —CH 2 CH 2 CH 2 CH 2 CH 2 —; Y is —CH 2 —, —CH 2 CH 2 —, —CH 2 CH 2 CH 2 —, —CH 2 CH 2 CH 2 CH 2 —, or —CH 2 CH 2 CH 2 CH 2 CH 2 —; X 1 is X 2 is and X 3 is 3. A salt, comprising a plurality of anions; and a cation represented by formula III: wherein, independently for each occurrence, each anion is X 1 is X 2 is X 3 is  and X 4 is 4. A salt, comprising a plurality of anions; and a cation represented by formula IV: wherein, independently for each occurrence, each anion is Z is —CH 2 CH 2 —, —CH 2 CH 2 CH 2 —, —CH 2 CH 2 CH 2 CH 2 —, or —CH 2 CH 2 CH 2 CH 2 CH 2 —; X 1 is X 2 is X 3 is  and X 4 is 5. The salt of claim 1 , wherein X 1 is 6. The salt of claim 1 , wherein X 1 is and X 2 is 7. The salt of claim 1 , wherein X 1 is and X 2 is 8. The salt of claim 1 , wherein Z is —CH 2 CH 2 —. 9. The salt of claim 1 , wherein Y is —CH 2 CH 2 —. 10. The salt of claim 1 , wherein Y is —CH 2 CH 2 —; and Z is —CH 2 CH 2 —. 11. The salt of claim 1 , wherein each anion is 12. The salt of claim 1 , wherein each anion is 13. The salt of claim 1 , wherein each anion is 14. A composition, comprising a protein; and a salt of claim 1 . 15. The composition of claim 14 , wherein the protein is selected from the group consisting of antibodies and enzymes. 16. A method of increasing shelf life of an aqueous solution of a protein, comprising: combining an aqueous solution of a protein and an effective amount of a salt of claim 1 . 17. The method of claim 16 , wherein the protein is selected from the group consisting of antibodies and enzymes. 18. A method of decreasing the amount of protein aggregation in an aqueous solution of a protein, comprising: combining an aqueous solution of a protein and an effective amount of a salt of claim 1 . 19. The method of claim 18 , wherein the protein is selected from the group consisting of antibodies and enzymes.

Assignees

Inventors

Classifications

  • C12N9/96Primary

    Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates · CPC title

  • being further substituted by nitrogen atoms not being part of nitro or nitroso groups · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9410142B2 cover?
One aspect of the invention is a salt comprising guanidinium groups, as shown in formula I. Another aspect of the invention is a salt comprising guanidinium groups, as shown in formula II. Another aspect of the invention is a salt comprising guanidinium groups, as shown in formula III. Another aspect of the invention is a salt comprising guanidinium groups, as shown in formula IV. Yet another a…
Who is the assignee on this patent?
Trout Ii Bernhardt L, Shukla Diwakar, Schneider Curtiss P, and 1 more
What technology area does this patent fall under?
Primary CPC classification C12N9/96. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).